top biopharmaceuticals for glp-1 medication 3 Companies at the Forefront of the Pill Wars Emerging New Drug Modalities in

Top 20 Companies in Global Glucagon-Like Peptide-1 Agonists Market (20262035): Expert View By Spherical Insights RELEASE DATE: May 2026 Author: Spherical Insights According to a research report published by Spherical Insights & Consulting, The Global Glucagon-Like Peptide-1 Agonists Market size is projected to grow from USD 46.18 Billion in 2025 to USD 160.42 Billion by 2035, at a CAGR of 13.28% during the forecast period 20262035

Rising adoption of oral GLP-1 drugs The growing take up of oral GLP-1 medicines is, in a way, re-shaping the global GLP-1 agonists market

It works by mimicking the action of the GLP-1 hormone, which regulates appetite and food intake

They keep pushing forward with research thats tied to metabolic disorders and more advanced care options